NO952207L - Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel - Google Patents

Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel

Info

Publication number
NO952207L
NO952207L NO952207A NO952207A NO952207L NO 952207 L NO952207 L NO 952207L NO 952207 A NO952207 A NO 952207A NO 952207 A NO952207 A NO 952207A NO 952207 L NO952207 L NO 952207L
Authority
NO
Norway
Prior art keywords
antidepressant
tetrahydrobenzothiazole
pramipexole
propylamino
amino
Prior art date
Application number
NO952207A
Other languages
English (en)
Other versions
NO952207D0 (no
NO306930B1 (no
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO952207L publication Critical patent/NO952207L/no
Publication of NO952207D0 publication Critical patent/NO952207D0/no
Publication of NO306930B1 publication Critical patent/NO306930B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO952207A 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel NO306930B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (3)

Publication Number Publication Date
NO952207L true NO952207L (no) 1995-06-02
NO952207D0 NO952207D0 (no) 1995-06-02
NO306930B1 NO306930B1 (no) 2000-01-17

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952207A NO306930B1 (no) 1992-12-05 1995-06-02 Anvendelse av 2-amino-6-n-propylamino-4,5,6,7- tetrahydrobenzotiazol (Pramipexol) som et antidepressivt middel

Country Status (29)

Country Link
US (1) US6191153B1 (no)
EP (1) EP0675717B1 (no)
JP (1) JP3221880B2 (no)
KR (1) KR100311165B1 (no)
CN (1) CN1052400C (no)
AT (1) ATE183091T1 (no)
AU (1) AU674378B2 (no)
BG (1) BG62475B1 (no)
CA (1) CA2150131C (no)
CZ (1) CZ282679B6 (no)
DE (2) DE4241013A1 (no)
DK (1) DK0675717T3 (no)
ES (1) ES2136725T3 (no)
FI (1) FI952734A0 (no)
GR (1) GR3031521T3 (no)
HK (1) HK1019003A1 (no)
HU (1) HU221014B1 (no)
IL (1) IL107870A (no)
MX (1) MX9307644A (no)
NO (1) NO306930B1 (no)
NZ (1) NZ258876A (no)
PL (1) PL309282A1 (no)
RU (1) RU2157685C2 (no)
SG (1) SG49228A1 (no)
SK (1) SK281441B6 (no)
TW (1) TW362973B (no)
UA (1) UA35604C2 (no)
WO (1) WO1994013287A1 (no)
ZA (1) ZA939065B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
AU2001278875B2 (en) * 2000-07-06 2007-06-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
ATE486588T1 (de) * 2004-08-13 2010-11-15 Boehringer Ingelheim Int Tablettenformulierung mit verlängerter freisetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon, herstellungsverfahren und verwendung dafür
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
EP1867641A4 (en) * 2005-04-04 2010-01-13 Takeda Pharmaceutical A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS
EP1940398A1 (de) * 2005-10-18 2008-07-09 Boehringer Ingelheim International GmbH Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
CN110730662A (zh) * 2017-04-10 2020-01-24 才思治疗公司 用于治疗共核蛋白病的nk1-拮抗剂组合和方法
US11266633B2 (en) * 2017-06-30 2022-03-08 Chase Therapeutics Corporation NK-1 antagonist compositions and methods for use in treating depression
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
HU221014B1 (hu) 2002-07-29
US6191153B1 (en) 2001-02-20
ES2136725T3 (es) 1999-12-01
JPH08504201A (ja) 1996-05-07
KR100311165B1 (ko) 2001-12-28
EP0675717A1 (de) 1995-10-11
AU674378B2 (en) 1996-12-19
NZ258876A (en) 1997-07-27
TW362973B (en) 1999-07-01
EP0675717B1 (de) 1999-08-11
SK74095A3 (en) 1996-05-08
CN1091635A (zh) 1994-09-07
CA2150131A1 (en) 1994-06-23
WO1994013287A1 (de) 1994-06-23
CZ144095A3 (en) 1996-03-13
DE4241013A1 (de) 1994-06-09
RU2157685C2 (ru) 2000-10-20
FI952734A (fi) 1995-06-05
CN1052400C (zh) 2000-05-17
BG62475B1 (bg) 1999-12-30
JP3221880B2 (ja) 2001-10-22
GR3031521T3 (en) 2000-01-31
SG49228A1 (en) 1998-05-18
HK1019003A1 (en) 2000-01-14
NO952207D0 (no) 1995-06-02
MX9307644A (es) 1994-06-30
DK0675717T3 (da) 2000-02-28
FI952734A0 (fi) 1995-06-05
CZ282679B6 (cs) 1997-08-13
KR950703953A (ko) 1995-11-17
BG99700A (bg) 1996-04-30
UA35604C2 (uk) 2001-04-16
CA2150131C (en) 2004-09-21
PL309282A1 (en) 1995-10-02
IL107870A (en) 1996-12-05
IL107870A0 (en) 1994-04-12
HUT71798A (en) 1996-02-28
NO306930B1 (no) 2000-01-17
ATE183091T1 (de) 1999-08-15
HU9501623D0 (en) 1995-08-28
AU5715294A (en) 1994-07-04
ZA939065B (en) 1994-08-04
SK281441B6 (sk) 2001-03-12
DE59309733D1 (de) 1999-09-16

Similar Documents

Publication Publication Date Title
NO952207D0 (no) Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
DK0559019T3 (da) 14-beta-hydroxy-10-deacetyl-baccatin III og derivater deraf som antitumormidler
MX9203032A (es) Una solucion farmaceutica.
FI860842A0 (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
NO930773D0 (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
NO852245L (no) Anvendelse av visse forbindelser som fortilsetning.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
NO884005L (no) Fluorerte derivater av aminosyrer saerlig for bruk som overflateaktive midler.
FI915245A (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FI933928A0 (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel
KR890701578A (ko) 신규의 티오펜 화합물 및 그들의 제법
SU1464319A1 (ru) Коронароактивное антиишемическое средство
PT1097145E (pt) Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью

Legal Events

Date Code Title Description
MK1K Patent expired